Unlocking the potential of engineered immune cell therapy for solid tumors

Víctor Albarrán-Fernández (), Laura Angelats, Julio Delgado, Alena Gros, Álvaro Urbano-Ispizua, Sònia Guedan and Aleix Prat
Additional contact information
Víctor Albarrán-Fernández: Hospital Clínic
Laura Angelats: Hospital Clínic
Julio Delgado: Hospital Clínic
Alena Gros: Vall d’Hebron Hospital Campus
Álvaro Urbano-Ispizua: Hospital Clínic
Sònia Guedan: August Pi I Sunyer Biomedical Research Institute (IDIBAPS)
Aleix Prat: Hospital Clínic

Nature Communications, 2025, vol. 16, issue 1, 1-5

Abstract: Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.

Date: 2025
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-56527-0 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56527-0

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-56527-0

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().